These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17996442)

  • 21. Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort.
    Tareen B; Sankin A; Godoy G; Temkin S; Lepor H; Taneja SS
    Urology; 2009 Feb; 73(2):351-4; discussion 354-5. PubMed ID: 19038430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is a positive bladder neck margin truly a T4 lesion in the prostate specific antigen era? Results from the SEARCH Database.
    Buschemeyer WC; Hamilton RJ; Aronson WJ; Presti JC; Terris MK; Kane CJ; Amling CL; Freedland SJ
    J Urol; 2008 Jan; 179(1):124-9; discussion 129. PubMed ID: 17997433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying the impact of prostate volumes, number of biopsy cores and 5alpha-reductase inhibitor therapy on the probability of prostate cancer detection using mathematical modeling.
    Serfling R; Shulman M; Thompson GL; Xiao Z; Benaim E; Roehrborn CG; Rittmaster R
    J Urol; 2007 Jun; 177(6):2352-6. PubMed ID: 17509357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perineural invasion is a prognostic factor for biochemical failure after radical prostatectomy.
    Jeon HG; Bae J; Yi JS; Hwang IS; Lee SE; Lee E
    Int J Urol; 2009 Aug; 16(8):682-6. PubMed ID: 19602004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Survival after radical prostatectomy in patients with prostate cancer and seminal vesicle invasion].
    Castillejos-Molina RA; Rodríguez-Covarrubias F; Sotomayor de Zavaleta M; Uribe-Uribe N; Lino LS; Feria-Bernal G
    Rev Invest Clin; 2008; 60(5):360-4. PubMed ID: 19227432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small prostate size and high grade disease--biology or artifact?
    Liu JJ; Brooks JD; Ferrari M; Nolley R; Presti JC
    J Urol; 2011 Jun; 185(6):2108-11. PubMed ID: 21496855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.
    Gallina A; Chun FK; Suardi N; Eastham JA; Perrotte P; Graefen M; Hutterer G; Huland H; Klein EA; Reuther A; Montorsi F; Briganti A; Shariat SF; Roehrborn CG; de la Taille A; Salomon L; Karakiewicz PI
    BJU Int; 2008 Jun; 101(12):1513-8. PubMed ID: 18422773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial.
    Cohen YC; Liu KS; Heyden NL; Carides AD; Anderson KM; Daifotis AG; Gann PH
    J Natl Cancer Inst; 2007 Sep; 99(18):1366-74. PubMed ID: 17848668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Volume-related sequence of tumor distribution pattern in prostate carcinoma: importance of posterior midline crossover in predicting tumor volume, extracapsular extension, and seminal vesicle invasion.
    Torlakovic G; Torlakovic E; Skovlund E; Nesland JM; Reith A; Danielsen HE
    Croat Med J; 2005 Jun; 46(3):429-35. PubMed ID: 15861523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of positive surgical margins after radical perineal prostatectomy.
    Goetzl MA; Krebill R; Griebling TL; Thrasher JB
    Can J Urol; 2009 Apr; 16(2):4553-7. PubMed ID: 19364427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates.
    Sajadi KP; Kim T; Terris MK; Brown JA; Lewis RW
    Urology; 2007 Oct; 70(4):691-5. PubMed ID: 17991539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percent tumor involvement and risk of biochemical progression after radical prostatectomy.
    Rampersaud EN; Sun L; Moul JW; Madden J; Freedland SJ
    J Urol; 2008 Aug; 180(2):571-6; discussion 576. PubMed ID: 18554662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA ploidy by image analysis of individual foci of prostate cancer: a preliminary report.
    Greene DR; Taylor SR; Wheeler TM; Scardino PT
    Cancer Res; 1991 Aug; 51(15):4084-9. PubMed ID: 1855223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of prostate size and tumor grade in Korean men with clinically localized prostate cancer.
    Hong SK; Yu JH; Han BK; Chang IH; Jeong SJ; Byun SS; Lee HJ; Choe G; Lee SE
    Urology; 2007 Jul; 70(1):91-5. PubMed ID: 17656215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features.
    Cohen RJ; Shannon BA; Phillips M; Moorin RE; Wheeler TM; Garrett KL
    J Urol; 2008 May; 179(5):1762-7; discussion 1767. PubMed ID: 18343454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
    Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y
    Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy.
    Schroeck FR; Sun L; Freedland SJ; Jayachandran J; Robertson CN; Moul JW
    Prostate Cancer Prostatic Dis; 2008; 11(4):371-6. PubMed ID: 18427570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a large prostate gland on open and robotically assisted laparoscopic radical prostatectomy.
    Chan RC; Barocas DA; Chang SS; Herrell SD; Clark PE; Baumgartner R; Smith JA; Cookson MS
    BJU Int; 2008 May; 101(9):1140-4. PubMed ID: 18399829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.